SPARK-ALL: Calaspargase Pegol in Adults With ALL

NCT04817761 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

42

Enrollment

OTHER

Sponsor class

Stopped Sponsor decision

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG: Calaspargase pegol (S95015)

Sponsor

Institut de Recherches Internationales Servier

Collaborators

[object Object]